Search Menu Board of Directors Enrico Vanni, Ph.D. Vice Chairman since 2011 | Lead Independent Director since January 1, 2021 Nationality: Swiss | Year of birth: 1951 Enrico Vanni is an expert in business management, healthcare and technology who began his career as a research engineer at the International Business Machines Corp. (IBM) in the US. He later joined McKinsey & Co. in Switzerland, where he managed the Geneva office and led the firm’s European pharmaceutical practice. Since retiring in 2007, Mr. Vanni has continued to support leaders of pharmaceutical and biotechnology companies on core strategic challenges facing the healthcare industry. Professional experience Independent consultant supporting leaders of pharmaceutical and biotechnology companies (2008–2015) Director, consulting in pharmaceutical, consumer and financial sectors, McKinsey & Co., Switzerland (1994–2007) Head of the Geneva office, McKinsey & Co., Switzerland (1988–2004) Mandates Board member, Advanced Oncotherapy PLC, UK Board member, Lombard Odier & Cie SA, Switzerland Board member, Banque Privée BCP (Suisse) SA, Switzerland Board member, Eclosion2 SA, Switzerland (2009–2017) Board member, Alcon Inc., Switzerland (2010–2011) Board member, Actavis PLC, Ireland (2010) Education Master of Business Administration, INSEAD, France Doctorate in physical chemistry, University of Lausanne, Switzerland Engineering degree in chemistry, Federal Polytechnic School of Lausanne, Switzerland Key skills Medicine/healthcare/R&D Finance/accounting Novartis Navigate Topics Explore Companies © 2021 Novartis AG Terms of Use Privacy Contacts Cookie Settings Site Map Novartis Site Directory This site is intended for a global audience